Cm Management, LLC Relmada Therapeutics, Inc. Transaction History

Cm Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$16.5 - $30.34 $247,500 - $455,100	-15,000 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$16.72 - $26.99 $83,600 - $134,950	5,000 Added 50.0%	15,000 $405,000
Q4 2021 Feb 02, 2022	BUY	$16.93 - $26.82 $169,300 - $268,200	10,000 New	10,000 $225,000

12.3M

229K

138K

Ticker RLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,608,500
Market Cap $10.3M
Description
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...

Get notified when there are updates to the investment portfolio of Cm Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cm Management, LLC with notifications on news.